N-imidazolyl derivatives of the napththalene and chroman rings as thromboxane A2 synthase inhibitors
- 1 June 1991
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 26 (4) , 423-433
- https://doi.org/10.1016/0223-5234(91)90103-t
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Plasma thromboxane and prostacyclin metabolite ratio in atherosclerosis and diabetes mellitusThrombosis Research, 1987
- The Role of Arachidonic Acid Metabolites in Renal HomeostasisDrugs, 1987
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shockIntensive Care Medicine, 1986
- Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.Journal of Clinical Investigation, 1985
- In vivo production of thromboxane in acute human myocardial infarction: A preliminary studyThrombosis Research, 1985
- Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregationProstaglandins, 1976
- Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxidesProstaglandins, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Prostaglandin Endoperoxides IX. Characterization of Rabbit Aorta Contracting Substance (RCS) from Guinea Pig Lung and Human PlateletsActa Physiologica Scandinavica, 1975